SVCT.LSE Seneca Growth Capital VCT plc
- Market cap
- GBX 8.94M
- P/E
- 0.6x
- P/B
- 0.88x
- ROE
- -18.7%
- Dividend yield
- 11.11%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is SVCT.LSE undervalued?
Graham numberThe Graham number of Seneca Growth Capital VCT plc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Seneca Growth Capital VCT plc fundamental analysis
No fundamental analysis for Seneca Growth Capital VCT plc yet.
Seneca Growth Capital VCT plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Seneca Growth Capital VCT plc
Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.
Full company profileSeneca Growth Capital VCT plc financial statements
Seneca Growth Capital VCT plc annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | -599K | -340K | 179K | -592K | 1.45M | 2.27M | -2.55M | -2.42M | -3.51M | -1.80M |
| Gross Profit | -599K | -340K | 179K | -592K | 1.45M | 2.27M | -2.55M | -2.42M | -3.51M | -1.80M |
| Operating Income | -616K | -367K | 66.0K | -715K | 1.30M | 2.10M | -2.75M | -2.67M | -3.74M | -2.03M |
| EBITDA | -582K | -367K | 66.0K | -715K | 1.30M | 2.10M | -2.75M | -2.67M | - | -2.03M |
| Net Income | -582K | -367K | 66.0K | -715K | 1.30M | 2.10M | -2.75M | -2.67M | -3.74M | -2.03M |
| EPS | -0.07 | -0.05 | 0.01 | -0.05 | 0.08 | 0.10 | -0.11 | -0.09 | -0.12 | -0.06 |
| Balance Sheet | ||||||||||
| Total Assets | 6.04M | 5.57M | 9.76M | 8.67M | 11.2M | 18.3M | 18.7M | 17.2M | 14.2M | 11.1M |
| Total Liabilities | 495K | 391K | 481K | 289K | 416K | 516K | 521K | 335K | 219K | 209K |
| Shareholders' Equity | 5.55M | 5.18M | 9.28M | 8.38M | 10.8M | 17.8M | 18.1M | 16.9M | 13.9M | 10.9M |
| Cash & Short-term Investments | -185K | -160K | 6.45M | 3.91M | 5.06M | 7.11M | 5.07M | 1.46M | 1.54M | 736K |
| Total Debt | 185K | 160K | - | - | - | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -132K | -109K | -106K | -138K | -194K | -288K | -481K | -459K | -257K | -219K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -132K | -109K | -106K | -138K | -194K | -288K | -481K | -459K | -257K | -219K |
| Ratios | ||||||||||
| ROE | -10.5% | -7.1% | 0.7% | -8.5% | 12.0% | 11.8% | -15.2% | -15.8% | -26.8% | -18.7% |
| ROA | -9.6% | -6.6% | 0.7% | -8.2% | 11.6% | 11.5% | -14.7% | -15.5% | -26.4% | -18.3% |
| Net Profit Margin | - | - | 36.9% | - | 89.5% | 92.5% | - | - | - | - |
| Debt to Equity | 0.03x | 0.03x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Seneca Growth Capital VCT plc dividends
- Dividend yield
- 11.11%
- Forward dividend
- 0.03 GBX
- Payout ratio
- -
- Ex-dividend date
- Sep 17, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | GBP 1.41M | 0.04 | - |
| 2024 | GBP 717K | 0.02 | - |
| 2023 | GBP 791K | 0.03 | - |
| 2022 | GBP 700K | 0.03 | - |
| 2021 | GBP 727K | 0.04 | 34.7% |
| 2020 | GBP 1.30M | 0.08 | 100.3% |
| 2019 | GBP 2.44M | 0.18 | - |
| 2018 | GBP 237K | 0.03 | 358.4% |
| 2017 | GBP 237K | 0.03 | - |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Seneca Growth Capital VCT plc
- Insiders 0.63%
- Institutions 0.00%
- Public & others 99.37%
- Shares outstanding 25.0M
- Free float 31.7M
Seneca Growth Capital VCT plc company profile
- Company name
- Seneca Growth Capital VCT plc
- Ticker
- SVCT.LSE
- Exchange
- London Exchange
- Sector
- Financial Services
- Industry
- Commercial Services & Supplies
- Fiscal year end
- December
- Address
- 12 The Parks, Newton-le-Willows, United Kingdom, WA12 0JQ
- Phone
- 44 19 4227 1746
- Website
- senecavct.co.uk
About Seneca Growth Capital VCT plc
Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.